Graham Capital Management, L.P. Dynavax Technologies Corp Transaction History

Graham Capital Management, L.P.

  • $4.42 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$13.09 - $14.98 $524,280 - $599,978
40,052 Added 383.13%
50,506 $706,000
Q3 2023

Nov 22, 2023
BUY
$12.64 - $14.99 $132,138 - $156,705
10,454 New
10,454 $154,000
Q1 2022

May 16, 2022
SELL
$9.75 - $14.44 $284,631 - $421,546
-29,193 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$13.17 - $20.94 $384,471 - $611,301
29,193 New
29,193 $410,000

Others Institutions Holding DVAX

# of Institutions
274
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.57B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email